HEALTH DISPARITIES AMONG PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE CASCADE-FH PATIENT REGISTRY

Background: Familial hypercholesterolemia (FH) patients require aggressive lipid lowering therapies to reduce cardiovascular disease risk. In the US, treatment patterns remain poorly described, and it remains unclear whether sex or ethnic/racial disparities exist. In 2013, the FH Foundation launched